Werewolf Therapeutics, Inc. SEC filings HOWL

Werewolf Therapeutics, Inc. has 450 filings in SEC EDGAR's recent list, going back to Aug 15, 2019. Its latest annual report, Form 10-K, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 31, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 21, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.

Werewolf Therapeutics, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G Ownership over 5% (passive) Sep 21, 2026 —
4 Insider transaction Jul 8, 2026 Jul 6, 2026
144 Notice of proposed sale Jul 6, 2026 —
144 Notice of proposed sale Jul 6, 2026 —
144 Notice of proposed sale Jul 6, 2026 —
144 Notice of proposed sale Jul 6, 2026 —
144 Notice of proposed sale Jul 6, 2026 —
144 Notice of proposed sale Jul 6, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 2, 2026 —
4 Insider transaction Jun 29, 2026 Jun 29, 2026
144 Notice of proposed sale Jun 29, 2026 —
144 Notice of proposed sale Jun 29, 2026 —
144 Notice of proposed sale Jun 29, 2026 —
144 Notice of proposed sale Jun 29, 2026 —
144 Notice of proposed sale Jun 29, 2026 —
144 Notice of proposed sale Jun 29, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 26, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 22, 2026 —
4 Insider transaction Jun 22, 2026 Jun 17, 2026
4 Insider transaction Jun 16, 2026 Jun 12, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 15, 2026 —
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 10, 2026 Jun 9, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction May 29, 2026 May 27, 2026
144 Notice of proposed sale May 28, 2026 —
144 Notice of proposed sale May 28, 2026 —
144 Notice of proposed sale May 28, 2026 —
144 Notice of proposed sale May 28, 2026 —
144 Notice of proposed sale May 28, 2026 —
144 Notice of proposed sale May 28, 2026 —
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 20, 2026 May 18, 2026
144 Notice of proposed sale May 18, 2026 —
144 Notice of proposed sale May 18, 2026 —
144 Notice of proposed sale May 18, 2026 —
144 Notice of proposed sale May 18, 2026 —
144 Notice of proposed sale May 18, 2026 —
144 Notice of proposed sale May 18, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) May 14, 2026 —
4 Insider transaction May 13, 2026 May 13, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) May 12, 2026 —
4 Insider transaction May 12, 2026 May 8, 2026
4 Insider transaction May 12, 2026 May 8, 2026
144 Notice of proposed sale May 11, 2026 —
144 Notice of proposed sale May 11, 2026 —
144 Notice of proposed sale May 11, 2026 —
144 Notice of proposed sale May 11, 2026 —
144 Notice of proposed sale May 11, 2026 —
144 Notice of proposed sale May 11, 2026 —
4 Insider transaction May 7, 2026 May 5, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) May 5, 2026 —
4 Insider transaction May 4, 2026 Apr 30, 2026
144 Notice of proposed sale May 1, 2026 —
144 Notice of proposed sale May 1, 2026 —
144 Notice of proposed sale May 1, 2026 —
144 Notice of proposed sale May 1, 2026 —
144 Notice of proposed sale May 1, 2026 —
144 Notice of proposed sale May 1, 2026 —
4 Insider transaction Apr 29, 2026 Apr 27, 2026
144 Notice of proposed sale Apr 29, 2026 —
144 Notice of proposed sale Apr 29, 2026 —
144 Notice of proposed sale Apr 29, 2026 —
144 Notice of proposed sale Apr 29, 2026 —
144 Notice of proposed sale Apr 29, 2026 —
144 Notice of proposed sale Apr 29, 2026 —
144 Notice of proposed sale Apr 27, 2026 —
144 Notice of proposed sale Apr 27, 2026 —
144 Notice of proposed sale Apr 27, 2026 —
144 Notice of proposed sale Apr 27, 2026 —
144 Notice of proposed sale Apr 27, 2026 —
144 Notice of proposed sale Apr 27, 2026 —
3 Initial insider ownership Mar 13, 2026 Feb 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 11, 2026 —
4 Insider transaction Jan 20, 2026 Jan 16, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 16, 2026 —
4 Insider transaction Jan 15, 2026 Jan 13, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 7, 2026 Jan 5, 2026
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
4 Insider transaction Jan 2, 2026 Dec 30, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 29, 2025 —
4 Insider transaction Dec 29, 2025 Dec 22, 2025
144 Notice of proposed sale Dec 29, 2025 —
144 Notice of proposed sale Dec 29, 2025 —
144 Notice of proposed sale Dec 29, 2025 —
144 Notice of proposed sale Dec 29, 2025 —
144 Notice of proposed sale Dec 29, 2025 —
144 Notice of proposed sale Dec 29, 2025 —
144 Notice of proposed sale Dec 22, 2025 —
144 Notice of proposed sale Dec 22, 2025 —
144 Notice of proposed sale Dec 22, 2025 —
144 Notice of proposed sale Dec 22, 2025 —
144 Notice of proposed sale Dec 22, 2025 —
144 Notice of proposed sale Dec 22, 2025 —
4 Insider transaction Dec 17, 2025 Dec 15, 2025
4 Insider transaction Dec 12, 2025 Dec 10, 2025
144 Notice of proposed sale Dec 10, 2025 —
144 Notice of proposed sale Dec 10, 2025 —
144 Notice of proposed sale Dec 10, 2025 —
144 Notice of proposed sale Dec 10, 2025 —
144 Notice of proposed sale Dec 10, 2025 —
144 Notice of proposed sale Dec 10, 2025 —
4 Insider transaction Dec 9, 2025 Dec 5, 2025
4 Insider transaction Dec 4, 2025 Dec 2, 2025
4 Insider transaction Dec 4, 2025 Dec 2, 2025
4 Insider transaction Dec 4, 2025 Dec 2, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 3, 2025 —
144 Notice of proposed sale Dec 3, 2025 —
144 Notice of proposed sale Dec 3, 2025 —
144 Notice of proposed sale Dec 3, 2025 —
144 Notice of proposed sale Dec 3, 2025 —
144 Notice of proposed sale Dec 3, 2025 —
144 Notice of proposed sale Dec 3, 2025 —
4 Insider transaction Dec 1, 2025 Nov 26, 2025
4 Insider transaction Dec 1, 2025 Nov 26, 2025
4 Insider transaction Dec 1, 2025 Nov 26, 2025
4 Insider transaction Nov 25, 2025 Nov 21, 2025
4 Insider transaction Nov 25, 2025 Nov 21, 2025
4 Insider transaction Nov 25, 2025 Nov 21, 2025
144 Notice of proposed sale Nov 24, 2025 —
144 Notice of proposed sale Nov 24, 2025 —
144 Notice of proposed sale Nov 24, 2025 —
144 Notice of proposed sale Nov 24, 2025 —
144 Notice of proposed sale Nov 24, 2025 —
144 Notice of proposed sale Nov 24, 2025 —
4 Insider transaction Nov 20, 2025 Nov 18, 2025
4 Insider transaction Nov 20, 2025 Nov 18, 2025
4 Insider transaction Nov 20, 2025 Nov 18, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 17, 2025 —
4 Insider transaction Nov 17, 2025 Nov 13, 2025
4 Insider transaction Nov 17, 2025 Nov 13, 2025
4 Insider transaction Nov 17, 2025 Nov 13, 2025
144 Notice of proposed sale Nov 17, 2025 —
144 Notice of proposed sale Nov 17, 2025 —
144 Notice of proposed sale Nov 17, 2025 —
144 Notice of proposed sale Nov 17, 2025 —
144 Notice of proposed sale Nov 17, 2025 —
144 Notice of proposed sale Nov 17, 2025 —
4 Insider transaction Nov 12, 2025 Nov 7, 2025
4 Insider transaction Nov 12, 2025 Nov 7, 2025
4 Insider transaction Nov 12, 2025 Nov 7, 2025
144 Notice of proposed sale Nov 10, 2025 —
144 Notice of proposed sale Nov 10, 2025 —
144 Notice of proposed sale Nov 10, 2025 —
144 Notice of proposed sale Nov 10, 2025 —
144 Notice of proposed sale Nov 10, 2025 —
144 Notice of proposed sale Nov 10, 2025 —
4 Insider transaction Nov 6, 2025 Nov 4, 2025
4 Insider transaction Nov 6, 2025 Nov 4, 2025
4 Insider transaction Nov 6, 2025 Nov 4, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 6, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 4, 2025 —
144 Notice of proposed sale Nov 4, 2025 —
144 Notice of proposed sale Nov 4, 2025 —
144 Notice of proposed sale Nov 4, 2025 —
144 Notice of proposed sale Nov 4, 2025 —
144 Notice of proposed sale Nov 4, 2025 —
144 Notice of proposed sale Nov 4, 2025 —
4 Insider transaction Nov 3, 2025 Oct 30, 2025
4 Insider transaction Nov 3, 2025 Oct 30, 2025
4 Insider transaction Nov 3, 2025 Oct 30, 2025
144 Notice of proposed sale Oct 30, 2025 —
144 Notice of proposed sale Oct 30, 2025 —
144 Notice of proposed sale Oct 30, 2025 —
144 Notice of proposed sale Oct 30, 2025 —
144 Notice of proposed sale Oct 30, 2025 —
144 Notice of proposed sale Oct 30, 2025 —
4 Insider transaction Oct 29, 2025 Oct 27, 2025
4 Insider transaction Oct 29, 2025 Oct 27, 2025
4 Insider transaction Oct 29, 2025 Oct 27, 2025
144 Notice of proposed sale Oct 27, 2025 —
144 Notice of proposed sale Oct 27, 2025 —
144 Notice of proposed sale Oct 27, 2025 —
144 Notice of proposed sale Oct 27, 2025 —
144 Notice of proposed sale Oct 27, 2025 —
144 Notice of proposed sale Oct 27, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) May 14, 2025 —
4 Insider transaction May 14, 2025 May 12, 2025
4 Insider transaction May 2, 2025 May 1, 2025
4 Insider transaction Apr 30, 2025 Mar 27, 2025
4 Insider transaction Apr 30, 2025 Mar 27, 2025
4 Insider transaction Apr 30, 2025 Mar 27, 2025
3 Initial insider ownership Apr 18, 2025 Apr 16, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
3 Initial insider ownership Feb 21, 2025 Feb 19, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
HOWL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Waltham, MA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1785530

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.